Simon Property Group (NYSE:SPG) Upgraded to “Overweight” at Piper Sandler
Simon Property Group (NYSE:SPG – Get Free Report) was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a research report issued on Wednesday, MarketBeat.com ...
Bausch Health cut to hold by Jefferies over B+L update
Jefferies has downgraded Bausch Health (NYSE:BHC) to hold from buy, citing news that a possible sale of its Bausch+Lomb (NYSE:BLCO) unit to a private equity group has fallen through. "While ownership ...
Eli Lilly Stock Rises After Profit, Outlook Top Expectations
Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...
Rosenblatt raises ARM Holdings stock target to $225, keeps Buy rating
Rosenblatt Securities adjusted its outlook for Arm Holdings (NASDAQ:ARM), increasing the price target on the company's stock to $225 from the previous $180. The firm has also reaffirmed its Buy rating ...
Jefferies Keeps Their Buy Rating on Broadcom (AVGO)
In a report released yesterday, Blayne Curtis from Jefferies reiterated a Buy rating on Broadcom (AVGO – Research Report). The company’s shares ...
Jefferies Sticks to Its Hold Rating for REA Group Ltd (RPGRF)
In a report released today, Roger Samuel from Jefferies maintained a Hold rating on REA Group Ltd (RPGRF – Research Report), with a price ...
The Financial Express23h
JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…
Jefferies maintains a Buy rating on JB Pharma citing strong CDMO growth potential and a 34% upside. Know more about it.